Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 04, 2026 15:47 ET | Source: Foundation for Sarcoidosis Research

FSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes

Foundation for Sarcoidosis Research Invests $700,000 Across Four Sarcoidosis Studies
August 03, 2026 12:02 ET | Source: Molecure SA

Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)

Molecure's Phase II KITE trial for OATD-01 in pulmonary sarcoidosis will continue without protocol changes following a positive IDMC review.
July 15, 2026 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
July 14, 2026 06:48 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry

Foundation for Sarcoidosis Research Launches New Clinical Data Registry
July 09, 2026 17:27 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Announces New Partnership with Patient Advocate Foundation to Expand Insurance and Disability Support for Sarcoidosis Patients

Foundation for Sarcoidosis Research Expands Insurance and Disability Support for Sarcoidosis Patients
May 11, 2026 16:01 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting
April 23, 2026 10:35 ET | Source: Foundation for Sarcoidosis Research

FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives

FSR and ATS are pleased to welcome joint new hire John Matthew “Matt” Craig, PhD.
April 01, 2026 07:04 ET | Source: Foundation for Sarcoidosis Research

A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month

Foundation for Sarcoidosis Research Launches See Sarcoidosis Campaign for April's Awareness Month
February 23, 2026 13:11 ET | Source: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Receives 2025 RareVoice Award for Federal Advocacy During Rare Disease Month

Foundation for Sarcoidosis Research is proud to receive 2025 RareVoice Award for Federal Advocacy and attend Rare Disease Month on Capitol Hill
January 21, 2026 11:08 ET | Source: Foundation for Sarcoidosis Research

FSR Announces $400,000 Investment in New Round of Cardiac and Pilot Grant Awards to Drive Breakthroughs in Diagnosis and Treatment of Sarcoidosis

FSR Invests in New Round of Research Awards to Drive Breakthroughs in Diagnosis and Treatment of Sarcoidosis